TrialThe Journal of infectious diseases2017

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).

Roy M Gulick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.